Office:	5150 Centre Avenue
	UPMC Cancer Pavilion, 5th floor
	Pittsburgh, PA 15232
Phone:	412-692-2607
Fax:	412-648-6579
E-mail:	liebermanf@upmc.edu

Education
	BA, Franklin and Marshall College, 1975
	MD, University of Chicago, 1979

Training
	Intern-Medicine, University of Chicago Hospitals, 1980
	Resident-Neurology, University of Chicago Hospitals, 1983
	Research Fellow-Neuro-Immunology, University of Chicago, 1985

Dr. Lieberman serves as the director of the adult neuro-oncology program within the University of Pittsburgh Cancer Institute, where I oversee the design and conduct of clinical trials for patients with primary and metastatic brain tumors. I have over 30 years of experience in the design and conduct of translational therapeutic trials for brain tumor patients and current serve as our institutions principal investigator for participation in the Adult Brain Tumor Consortium, NRG Consortium, and ECOG-ACRIN. I currently serve on the CNS Tumor committee, experimental imaging, and biomarker committees for ECOG-ACRIN. I have a focused expertise and interest in immunotherapeutic approaches to high and low grade gliomas. I have served and currently serve as principal investigator as well as co-investigator in glioma vaccine trials as well immune checkpoint inhibitor trials and in trials evaluating molecularly targeted therapeutic drugs. I am currently co-investigator on our institutional imaging projects assessing novel PET tracers and high field strength MRI spectroscopy and dynamic contrast imaging as early biomarkers of response in clinical trials for newly diagnosed and recurrent glioblastomas. I served as chair of the working group for Clinical Trials Design and Development for the NCI Quantitative Imaging Network. In collaboration with Marina Nikaforovna and Ronald Hamilton in the Department of Pathology, I have participated in the development of one of the largest molecular genomic databases for high and low grade gliomas in the US.

Dr. Lieberman currently serve as the director of the adult neuro-oncology program within the UPMC Hillman Cancer Center , where I oversee the care of patients with primary and metastatic brain and spinal cord tumors as well as complications of cancer involving the nervous system. I have over 30 years of experience in the care of patients with central nervous system tumors. In addition to a large outpatient consultation practice focusing primary brain tumors, metastatic brain and spinal cord tumors, and the neurologic complications of cancer and its treatment, I direct the inpatient neurooncology consult services serving the inpatient solid tumor oncology, hematologic malignancy, and hematopoetic stem cell transplantation services at Shadyside as well as neurosurgical services at Shadyside and Presbyterian Hospitals. Within the brain tumor practice, I have focused interest and expertise in low grade and malignant gliomas, ependymomas, and tumors associated with neurofibromatosis 1 and 2. Within the neurologic complications of cancer practice, I have focused interest and expertise in the diagnosis and management of paraneoplastic neurologic disorders and in the neurocognitive side effects of radiation therapy and drug therapies for cancer.

involved in resident and fellow teaching, supervising neurology and neurosurgery residents as well as hematology-oncology fellows. I oversee a combined inpatient and outpatient rotation in neurooncology for the neurology and neurosurgery residents and oversee hematology oncology fellows during the neurooncology component of the specialty clinic rotations. In addition I participate in neurology resident morning report, a teaching conference on the Oakland campus, and in neurology resident and hematology oncology journal clubs, and in the didactic conferences for both neurology and hematology- oncology trainees. I lecture in the Neoplasia course for 4th year students and serve as a facilitator in the 2nd year neuroscience course for medical students. At the national level, I am a member of the committee which wrote the first neurooncology subspecialty board examination for the UCNS, and currently serve on the committee revising the exam for 2017.

For my complete bibliography, Click Here.

Selected Publications: